Not a member? Sign up for free!

2019 PsychU National Forum: Future Of Technology & Mental Health

Live Program | June 25, 2019 9:00 am to 4:00 pm
You must be logged in to register for PsychU events.

Not a member? Sign up for free!

Join us as we continue our efforts towards improving the future of mental health care through information, discussion, and collaboration.
Sign up today for instant access to all PsychU offerings. Membership is free!

Join PsychU

Description

If you haven't already done so, please remember to take your Attendee Survey by Monday, June 17, 2019: https://psychu.org/psychu-national-forum-future-of-technology-and-mental-health-survey

Live Program: 2019 PsychU National Forum: Future of Technology and Mental Health

Location: Hyatt Regency O'Hare Chicago - 9300 W Bryn Mawr Ave, Rosemont, IL 60018

Description: This event, discussing the innovations, challenges, and benefits of digital health and technology in the mental health field, is being conducted on behalf of PsychU, by a small team of individuals from the Otsuka Pharmaceutical Development & Commercialization, Inc. Neuroscience Field Medical Affairs division. Members attending the event will be among their peers from other clinical and medical organizations and researchers whose focus is on mental health and technology.

  • Understand the current use of technology in mental health, and barriers that may limit implementation.
  • Discuss the future of implementing and advancing the use of technology in mental health
  • Gather key insights from technology and mental health experts to assist in the development of PsychU resources on technology in mental health.

Chair: John Kane, MD, Zucker HIllside

Moderator: Chip Meyer, Ph.D., Otsuka Pharmaceutical Development & Commercialization, Inc.

Agenda:

8:00-9:00 AM Breakfast

9:00–9:45 AM  Introductions & Objectives

  • Brief Introduction Of Participants (~15 Minutes)
  • Legal Ground Rules: Christina Van Derveer (~10 Minutes)
  • Objectives & Possible Outcomes (~5 Minutes)
  • Overview Of PsychU: Fatima Sadat (~10 Minutes)
  • Review Of Pre-Forum Survey: Mark Tacelosky (~5 Minutes)

9:45–10:45 AM  Current Use of Technology

  • Review Survey Questions
  • Discussion Questions

10:45–11:45 AM  Barriers to Using Technology in Mental Health

  • Review Survey Questions
  • Discussion Questions

11:45 AM–12:00 PM  Break / Gather Lunch

12:00–1:00 PM  Implementing the Use of Technology in Mental Health

  • Review Survey Questions
  • Discussion Questions

1:00–2:00 PM Future of the Use of Technology in Mental Health

  • Review Survey Questions
  • Discussion Questions

2:00-2:10 PM Break

2:10–3:10 PM  Educating On The Use of Technology in Mental Health

  • Review Survey Questions
  • Discussion Questions

3:10–3:35 PM  Desired Outcomes

3:35–4:00 PM  Final Remarks, Future Action Plan, Adjourn

Post Forum Objectives

  • Educational Deliverables for HCPs
    • Highlights/Summary
    • PsychU
      • Virtual Forum
      • Disease State Presentations
      • Mini Deck Presentations

Event Speakers

John M. Kane, MD
Forum Chair

John M. Kane, MD, is Senior Vice President for Behavioral Health Services at Northwell Health. He is Professor and Chairman of Psychiatry at The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell in Hempstead, New York. He also serves as Chairman of Psychiatry at The Zucker Hillside Hospital in Glen Oaks, New York. Dr. Kane received a BA from Cornell University and earned his medical degree from New York University School of Medicine. He completed his residency in Psychiatry at The Zucker Hillside Hospital. He is a Diplomate of the American Board of Psychiatry and Neurology.

Dr. Kane is the recipient of many awards, including: the Lieber Prize; The APA’s Kempf Award, the Gralnick Award and Foundations Prize; the New York State Office of Mental Health Lifetime Achievement Award; The Dean Award from the American College of Psychiatrists and the Schizophrenia International Research Society Distinguished Service Award. He has served as President of the American Society of Clinical Psychopharmacology, the Psychiatric Research Society and the Schizophrenia International Research Society. Dr. Kane has been the principal investigator for research projects focusing on schizophrenia psychobiology, treatment and recovery, as well as improving the quality and cost of care. He is the author of 600 peer-reviewed papers and serves on the editorial boards of numerous journals.

Timothy Aungst, PharmD
Forum Attendee

Timothy Aungst, PharmD is an Associate Professor of Pharmacy Practice at MCPHS University, Worcester, MA. In 2011, he graduated from Wilkes University Nesbitt School of Pharmacy, Wilkes-Barre, Pennsylvania. Afterwards, he pursued a PGY-1 Pharmacy Practice Residency at St. Luke’s University Hospital, Bethlehem, Pennsylvania, with an emphasis on Internal Medicine, Cardiology, and Geriatric Care. He then completed a fellowship program focused on geriatric care, Medicare/Medicaid and drug management, and academia. While completing his post-grad training, he began consulting for multiple companies on mHealth and digital Health, with a specific focus on mobile apps. Since then, he has conducted research on digital health technologies in the pharmacy space, has been published in multiple peer review journals, and has spoken at multiple venues on the topics. He hopes to inspire the pharmacy profession to further integrate digital health into patient care, as well as raise awareness on the future possibilities posed in the coming decades.

Jake Behrens, MD
Forum Attendee

Dr. Behrens is a board-certified psychiatrist and fellow of the American Psychiatric Association. He completed his psychiatric residency at the University of Wisconsin where he served as a Chief Resident. He obtained his medical degree from the University of Wisconsin School of Medicine and Public Health and obtained his Bachelor’s of Science degree in Genetics from the University of Wisconsin-Madison.

Dror Ben-Zeev, PhD
Forum Attendee

Dror Ben-Zeev, PhD, is a Professor of Psychiatry and Behavioral Sciences at the University of Washington (UW), as well as a licensed Clinical Psychologist who specializes in the development and evaluation of technology-based approaches in the study, assessment, treatment, and prevention of mental illness. Dr. Ben-Zeev serves as the Co-Director of UW’s Behavioral Research in Technology and Engineering (BRiTE) Center, as well as the Director of the mHealth for Mental Health Program, a multidisciplinary effort to harness mobile technology to improve the outcomes and support the recovery of people with psychiatric conditions. His innovative digital health work includes development of illness self-management apps for individuals with schizophrenia, leveraging mobile and context-aware technologies for assessment of violence and suicidality in psychiatric hospital settings, behavioral sensing and modelling systems for detection of psychotic relapses, social media-based outreach and remote data collection involving people who experience auditory hallucinations, and clinical texting interventions for individuals with serious mental illness in community settings.

Dr. Ben-Zeev’s research has been supported by grants and awards from the National Institutes of Health (NIH) National Science Foundation (NSF) Center for Medicare and Medicaid Innovation (CMMI) Patient Centered Outcomes Research Institute (PCORI), SYNERGY Clinical and Translational Science Institute, Myrtlewood Foundation, Pivotal Ventures, VA Health Services Research & Development (HSR&D), and John Sloan Dickey Center for International Understanding. He has published editorials and commentaries on the use of technology-based interventions for Psychiatric Services, Nature Human Behaviour, the BMJ, and the New York Times. Ben-Zeev’s research has been covered by National Public Radio, The Washington Post, Nature, Wired Magazine, Slate, and The Economist. He currently serves as the Inaugural Editor of the “Technology in Mental Health” Column for Psychiatric Services, an APA journal.​ Dr. Ben-Zeev publishes extensively in scientific journals and is a regular speaker at national and international scientific meetings including invited presentations at the National Institute of Mental Health Director’s Innovation Speaker series, the National Academies, and the White House.

Megan Coder, PharmD, MBA
Forum Attendee

Megan Coder, PharmD, MBA, is Executive Director of the Digital Therapeutics Alliance. DTA’s mission is to broaden the understanding, adoption, and integration of clinically-evaluated digital therapeutics into mainstream healthcare through education, advocacy, and research.

With more than a decade of experience in the healthcare industry, Megan’s expertise extends from strategic growth and partnership development within the digital health sector, to the direct delivery of patient care. Prior to joining DTA, Megan worked with Voluntis, Iodine, the Pharmaceutical Care Management Association, and the Pharmacy Technician Certification Board.

A proud Badger, Megan graduated from the University of Wisconsin—Madison School of Pharmacy and completed an Executive Residency in Association Management & Leadership with the American Pharmacists Association.

Carmen Kosicek, MSN, APNP, PMHNP-BC
Forum Attendee

Carmen Kosicek, MSN, APNP, PMHNP-BC, is a national collegiate clinical educator of APNP clinical residents, pharmacy students, and physician assistant students at the company she founded and runs, Alay Health Team. Over 38 colleges, with students from across the nation, learn from Carmen via telepsychiatry, or onsight, at Alay Health Team where she shares her innovative, wholistic approach in the psychiatry and addiction arenas of healthcare. Carmen has two post graduate certifications, Psychiatric Mental Health Nurse Practitioner (PMHNP-BC) and a Certificate in Nurse Midwifery. Case Western Reserve University in Cleveland, Ohio is where she earned her Master of Science in Nursing. Her company that she founded, runs and practices at, spans the states of Wisconsin and Oregon, with over 2100 psychiatric clients across the age span. 70% of the practice, is done via telepsychiatry into rural markets.

David C. Mohr, PhD
Forum Attendee

David C. Mohr, Ph.D., trained as a psychologist, is Professor of Preventive Medicine in the Northwestern University Feinberg School of Medicine, with appointments in Departments of Psychiatry and Medical Social Sciences.  He is also the Director of Northwestern University’s Center for Behavioral Intervention Technologies (CBITs; www.cbits.northwestern.edu). Dr. Mohr’s work lies at the intersection of behavioral science, technology, and clinical research, focusing on the design and implementation of interventions that harness wireless and web-based technologies to promote mental health and wellness. While there has been much research over the past decades demonstrating the potential for digital mental health, successful implementation in healthcare settings has been elusive.  The overarching goal of this work is to sustainably implement digital mental health interventions in real-world care settings.  Dr. Mohr’s research has been consistently funded for more than 25 years by the United States National Institutes of Health, numerous other federal agencies, and foundations, resulting in over 200 peer-reviewed publications, and more than 25 book chapters.

John W. Newcomer, M.D.
Forum Attendee

Dr. John W. Newcomer is President and CEO of South Florida Behavioral Health Network, Inc. (d.b.a., Thriving Mind South Florida), the non-profit organization that oversees safety net mental health and substance use disorder services for Miami-Dade and Monroe counties, with annual funding of over $90 million from Florida’s Department of Children and Families as well as other federal and private sources. Dr. Newcomer is also an Adjunct Professor of Psychiatry at Washington University School of Medicine in St. Louis. He previously served as Vice Dean for the medical school and Vice President for Research at Florida Atlantic University, and prior to that was Senior Associate Dean for Clinical Research at the University of Miami Miller School of Medicine. During more than two decades at Washington University, he served in leadership positions related to the National Institutes of Health (NIH) funded General Clinical Research Center, the NIH Clinical Translational Science Award and the Center for Clinical Studies. Dr. Newcomer has been a Principal Investigator on grants funded through the NIH and the Substance Abuse and Mental Health Services Administration (SAMHSA) for over 25 years. In the public sector he was Chair of the Medicaid Drug Utilization Review Board for the State of Missouri for 13 years.

Joseph Parks, M.D.
Forum Attendee

Dr. Parks is the Medical Director for the National Council for Behavioral Health. He has nearly two decades of experience with public health. He was named director of the Missouri HealthNet Division of the Missouri Department of Social Services in 2013. Dr. Parks also holds the position of Distinguished Research Professor of Science at the University of Missouri – St. Louis and is a Clinical Assistant Professor of Psychiatry at the University of Missouri, Department of Psychiatry in Columbia. He practices psychiatry on an outpatient basis at Family Health Center, a federally funded community health center established to expand services to uninsured and underinsured patients in central Missouri.

Previously, he served for many years as Medical Director of the Missouri Department of Mental Health and as President of the Medical Director’s Council of the National Association of State Mental Health Program Director. Dr. Parks has also served as Director of the Missouri Institute of Mental Health at University of Missouri St Louis and as Division Director for the Division of Comprehensive Psychiatric Services of Missouri Department of Mental Health.

Areas of Expertise:  Certified Community Behavioral Health Centers (CCBHCs); Clinical Best Practices; Data-informed Care; Health Information Technology; Integration of Primary Care and Behavioral Health; Leadership Development; Trauma-informed Care; Workforce Development

Mona Sobhani, PhD
Forum Attendee

Mona Sobhani, PhD is Director of Research and Operations at the USC Center for Body Computing (CBC), a digital health research and innovation center.  By training, she is a cognitive neuroscientist with behavioral, physiological, and neuroimaging research experience in psychopathic traits, mirror neurons, emotion regulation, fear conditioning, and sensory-motor feedback.  She became interested in digital health solutions after consulting for NextGxDx, an online marketplace for genetic testing.  At the CBC, she overlooks the Center’s operations and the multitude of research projects and collaborations with digital health companies, health systems, care providers, payers, sports teams and leagues, and US Military divisions. Through her work at the CBC, Dr. Sobhani has designed and managed multi-site research studies investigating the relationship between health outcomes and technology, including wearable devices and mobile apps.  She is also deeply interested in the issues surrounding the adoption of digital tools, such as data ethics, privacy, and cybersecurity.  Previously, she completed a post-doctoral fellowship at Vanderbilt University with the MacArthur Foundation Law and Neuroscience Project. She was also a scholar with the Saks Institute for Mental Health Law, Policy, and Ethics where she worked with Elyn Saks, JD on the topic of the criminalization of mental illness. Dr. Sobhani holds a Ph.D. in Neuroscience from the University of Southern California, where her dissertation work investigated the relationship between psychopathic traits and the functional and structural connectivity of the fronto-amygdala neural circuit. She also holds a B.S. in Animal Physiology and Neuroscience from the University of California, San Diego.

Dawn Velligan, Ph.D.
Forum Attendee

Dr. Dawn Velligan is a Professor in the Department of Psychiatry, Chief of the Division of Community Recovery, Research and Training, and Henry B. Dielmann Chair at the University of Texas Health Science Center at San Antonio.  She received her training in clinical psychology at the University of California and Mental Health Clinical Research Center for Schizophrenia in Los Angeles.  In 1989, Dr. Velligan moved to Texas to assist in the development of a psychosis treatment and research unit.  Dr. Velligan’s internationally recognized research program focuses on the development and testing of psychosocial treatments to improve medication interest and follow through and outcomes in serious mental illness.   She developed Cognitive Adaptation Training (CAT) a unique treatment system designed to bypass the cognitive and motivational problems observed in serious mental illness and improve functional outcomes.    Dr. Velligan is author of numerous publications in high impact journals and she has received grant funding from the National Institute of Health, The National Alliance for Research on Schizophrenia and Depression, the Patient-Centered Outcomes research institute, industry and private foundations.  She frequently serves as a consultant to industry and scientific investigators in the areas of symptom assessment, medication adherence and follow through, cognition and outcomes.

Location

Name: Hyatt Regency
Street: 9300 W Bryn Mawr Ave
City/State: Rosemont, Illinois

Loading Map....
Hyatt Regency

9300 W Bryn Mawr Ave
Rosemont Illinois, 60018
You must be logged in to register for PsychU events.

Not a member? Sign up for free!

Join us as we continue our efforts towards improving the future of mental health care through information, discussion, and collaboration.
Sign up today for instant access to all PsychU offerings. Membership is free!

Join PsychU